MXCT
MaxCyte Inc
1.10$
+0.9%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -42.0% | -8.2% | -26.9% | -1.9% | -19.0% | -69.2% | -62.9% | -40.7% | -33.6% | -31.5% | -33.4% | -52.5% | -71.5% | -104.2% | |
| 2.3% | 1.7% | 1.3% | 1.0% | 0.9% | 1.0% | 2.1% | 2.8% | 4.0% | 4.2% | 6.1% | 11.1% | 11.2% | 15.6% | |
| 0.7% | 0.1% | 1.3% | 0.0% | 1.3% | 3.7% | 7.9% | 8.1% | 9.4% | 23.5% | 26.6% | 33.9% | 33.9% | 27.9% | |
| – | – | – | – | – | 4.4% | 9.0% | 8.6% | 10.9% | 25.4% | 26.9% | – | – | – | |
| -6.4% | 3.2% | -4.9% | 11.6% | 5.5% | -3.7% | -20.7% | 7.5% | -3.3% | -4.9% | -7.3% | 9.3% | -1.9% | -18.5% | |
| 0.3% | 0.7% | 2.1% | 1.0% | 1.8% | 4.4% | 4.3% | 5.9% | 7.9% | 11.3% | 41.7% | 9.0% | 4.3% | 5.4% | |
| -0.2% | -0.7% | -2.1% | -1.0% | -1.8% | -4.4% | -23.0% | 2.1% | -63.4% | -575.4% | -56.1% | 133.2% | 17.9% | 78.5% | |
| – | – | – | – | – | – | – | – | – | 707.2% | 6.5% | 0.7% | 1.2% | – | |
| – | – | – | – | – | -0.1% | 0.0% | -0.7% | -0.2% | -14.7% | 0.0% | – | – | – | |
| 27.1% | -0.7% | 65.8% | -7.8% | 96.7% | 170.9% | 1.4% | 56.9% | 110.5% | 692.5% | 6.5% | 5.2% | 5.3% | 2.0% | |
| -15.2% | -9.6% | 36.9% | -10.7% | 75.9% | 97.4% | -84.6% | 18.3% | 13.5% | 85.6% | -83.0% | 85.8% | -48.2% | -23.7% | |
| -42.4% | -8.9% | -28.9% | -3.0% | -20.8% | -73.6% | -67.2% | -46.6% | -41.5% | -42.8% | -75.1% | -61.5% | -75.8% | -109.5% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.